| Line Item | 2022-12-30 | Y/Y |
|---|---|---|
| Revenue | $1.04B | -52.9% |
| Cost of Revenue | $991.0M | -24.8% |
| Gross Profit | $48.7M | -94.5% |
| R&D Expense | $64.2M | -68.7% |
| SG&A Expense | $290.1M | -50.1% |
| Operating Income | -$316.7M | -56.1% |
| Interest Expense | $324.3M | +45.7% |
| Pre-tax Income | -$650.3M | +21.6% |
| Income Tax | -$52.0M | +51.1% |
| Net Income | -$598.1M | +16.6% |
| EPS (Basic) | -$45.41 | -436.1% |
| EPS (Diluted) | -$45.41 | -436.1% |
| Line Item | 2022-12-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $409.5M | -69.6% |
| Accounts Receivable | $405.3M | -7.7% |
| Inventory | $947.6M | +172.9% |
| Current Assets | $2.04B | -11.9% |
| Total Assets | $6.01B | -32.6% |
| Current Liabilities | $743.8M | -61.7% |
| Long-term Debt | $3.49B | — |
| Line Item | 2022-12-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $47.1M | -89.7% |
| Capital Expenditures | $28.8M | -47.9% |
| Investing Cash Flow | $27.5M | +172.8% |
| Financing Cash Flow | -$54.1M | +60.7% |
| Free Cash Flow | $18.3M | -95.4% |
| Total Liabilities |
| $4.40B |
| -48.9% |
| Stockholders' Equity | $1.61B | +414.9% |